GE Told To Pay $11.4M In False Advertising Case

Law360, New York (March 30, 2009, 12:00 AM EDT) -- GE Healthcare has been ordered to pay $11.4 million in damages to rival Bracco Diagnostics Inc. in a false advertising case over competing lines of intravenous drugs used to provide contrast in X-ray images.

Judge Freda L. Wolfson of the U.S. District Court for the District of New Jersey on Wednesday issued a permanent injunction requiring GE Healthcare to correct advertising suggesting its contrast agent Visipaque is better than alternative agents, including Bracco's Isovue.

Despite issuing the injunction, Judge Wolfson found that most of GE Healthcare's...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.